Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Brief Admission Skane: Can Brief Admission Replace General Admission for Individuals With Self-harm and Acute Risk of Suicide

NCT02985047 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT02985047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02985047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Brief Admission Skane: Can Brief Admission Replace General Admission for Individuals With Self-harm and Acute Risk of Suicide
Lead sponsor
Region Skane
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2015
Completion date
August 10, 2018
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder, emergency services, psychiatric, self-injurious behavior, suicidal ideation, suicide, attempted